| 1 | controls | 25,164 |
| 2 | non-smokers | 581 |
| 3 | nonsmokers | 525 |
| 4 | normals | 180 |
| 5 | normotensives | 170 |
| 6 | nondiabetics | 156 |
| 7 | non-diabetics | 138 |
| 8 | noncarriers | 132 |
| 9 | omnivores | 58 |
| 10 | non-drinkers | 52 |
| 11 | nondrinkers | 38 |
| 12 | dads | 27 |
| 13 | lowlanders | 24 |
| 14 | non-vegetarians | 22 |
| 15 | nonblacks | 21 |
| 16 | 7-year-olds | 20 |
| 17 | oihr | 20 |
| 18 | logbooks | 17 |
| 19 | 2-year-olds | 15 |
| 20 | monolinguals | 15 |
| 21 | 10-year-olds | 14 |
| 22 | anapen | 14 |
| 23 | nonmusicians | 13 |
| 24 | smex | 13 |
| 25 | i.c.u | 12 |
| 26 | sdct | 12 |
| 27 | 18-year-olds | 11 |
| 28 | dromedaries | 11 |
| 29 | pbcs | 11 |
| 30 | mefloquine-artesunate | 10 |
| 31 | non-aas | 10 |
| 32 | non-tasters | 10 |
| 33 | shoola | 10 |
| 34 | wild-types | 10 |
| 35 | dbercp | 9 |
| 36 | hca-apn | 9 |
| 37 | r16 | 9 |
| 38 | v-rg | 9 |
| 39 | 14-year-olds | 8 |
| 40 | babble | 8 |
| 41 | ctbna | 8 |
| 42 | ddst-ii | 8 |
| 43 | f52 | 8 |
| 44 | h-br | 8 |
| 45 | lr-ca | 8 |
| 46 | non-firefighters | 8 |
| 47 | non-tnbc | 8 |
| 48 | srp+placebo | 8 |
| 49 | voh | 8 |
| 50 | as+mq | 7 |
| 51 | av2s3 | 7 |
| 52 | colostrum/milk | 7 |
| 53 | elderlies | 7 |
| 54 | g32 | 7 |
| 55 | l-advp | 7 |
| 56 | non-bathers | 7 |
| 57 | non-healers | 7 |
| 58 | normolipidemics | 7 |
| 59 | suhr | 7 |
| 60 | teetotalers | 7 |
| 61 | 1,3-bisphosphoglycerate | 6 |
| 62 | ccept | 6 |
| 63 | dbhc | 6 |
| 64 | ec-dl | 6 |
| 65 | formula-feeders | 6 |
| 66 | hcv-g1 | 6 |
| 67 | integuseal | 6 |
| 68 | m-aci | 6 |
| 69 | non-sao-patients | 6 |
| 70 | ntls | 6 |
| 71 | p.r | 6 |
| 72 | papls | 6 |
| 73 | seadiet | 6 |
| 74 | zes-fr | 6 |
| 75 | α-synucleinopathies | 6 |
| 76 | 1000g | 5 |
| 77 | achdf | 5 |
| 78 | c-patients | 5 |
| 79 | control-infants | 5 |
| 80 | htn-12wk | 5 |
| 81 | le- | 5 |
| 82 | leutivit | 5 |
| 83 | lovt | 5 |
| 84 | mncc-tt | 5 |
| 85 | non-converters | 5 |
| 86 | non-recruiters | 5 |
| 87 | non-repeaters | 5 |
| 88 | nondancers | 5 |
| 89 | nonimprovers | 5 |
| 90 | phq-deniers | 5 |
| 91 | pwh-o | 5 |
| 92 | s-tha | 5 |
| 93 | urixin | 5 |
| 94 | wky-sed | 5 |
| 95 | 16/58 | 4 |
| 96 | abt-200 | 4 |
| 97 | aklavik | 4 |
| 98 | arf-1 | 4 |
| 99 | cervicograms | 4 |
| 100 | cntr | 4 |
| 101 | dc3 | 4 |
| 102 | diastology | 4 |
| 103 | european-americans | 4 |
| 104 | fainters | 4 |
| 105 | group-nc | 4 |
| 106 | hyperopes | 4 |
| 107 | iso+c | 4 |
| 108 | lps-dc | 4 |
| 109 | ma- | 4 |
| 110 | moroccans | 4 |
| 111 | non-/modest- | 4 |
| 112 | non-immigrants | 4 |
| 113 | non-injectors | 4 |
| 114 | non-octogenarians | 4 |
| 115 | nonhypertensives | 4 |
| 116 | nonjoggers | 4 |
| 117 | nonoctogenarians | 4 |
| 118 | nrfhr | 4 |
| 119 | obeses | 4 |
| 120 | om-only | 4 |
| 121 | p48 | 4 |
| 122 | pneumonia-pp | 4 |
| 123 | postneonates | 4 |
| 124 | prednisolone- | 4 |
| 125 | second-borns | 4 |
| 126 | sow10 | 4 |
| 127 | tacrolimus/mmf/steroids | 4 |
| 128 | teedlw | 4 |
| 129 | tetraploids | 4 |
| 130 | vit2 | 4 |
| 131 | wing-a | 4 |
| 132 | woreda | 4 |
| 133 | 1,000/microl | 3 |
| 134 | 1-octadecene | 3 |
| 135 | 1.183 | 3 |
| 136 | 12/31/2011 | 3 |
| 137 | 12/37 | 3 |
| 138 | 45.2°c | 3 |
| 139 | 58/70 | 3 |
| 140 | 80/81 | 3 |
| 141 | abled-bodied | 3 |
| 142 | adv1 | 3 |
| 143 | apneics | 3 |
| 144 | arvms | 3 |
| 145 | bud200 | 3 |
| 146 | cbt+gn | 3 |
| 147 | cc5 | 3 |
| 148 | children/parents | 3 |
| 149 | compocool-wb | 3 |
| 150 | cpb-cabg | 3 |
| 151 | cq+s+p | 3 |
| 152 | defend-1 | 3 |
| 153 | dodecanol | 3 |
| 154 | e-pmma-b-pmps/sio2 | 3 |
| 155 | epalrestat | 3 |
| 156 | epiderm | 3 |
| 157 | escherichia/shigella | 3 |
| 158 | evidence-based-medicine | 3 |
| 159 | exercises/advice | 3 |
| 160 | ga20 | 3 |
| 161 | group-bar | 3 |
| 162 | hispanic/latinos | 3 |
| 163 | hypochondroplasia | 3 |
| 164 | imip/cs | 3 |
| 165 | ldl-cholesterolemia | 3 |
| 166 | mets-pla | 3 |
| 167 | mig-2 | 3 |
| 168 | moxotó | 3 |
| 169 | nct00038727 | 3 |
| 170 | never-douchers | 3 |
| 171 | non-alcoholics | 3 |
| 172 | non-ee-des | 3 |
| 173 | non-emp | 3 |
| 174 | non-gymnasts | 3 |
| 175 | non-switchers | 3 |
| 176 | noninitiators | 3 |
| 177 | noninsomniacs | 3 |
| 178 | nontriptans | 3 |
| 179 | olysetnet | 3 |
| 180 | p56 | 3 |
| 181 | parents/patients | 3 |
| 182 | pd51 | 3 |
| 183 | phononics | 3 |
| 184 | poultices | 3 |
| 185 | pre-emergence | 3 |
| 186 | propranolol+hfa-bdp100 | 3 |
| 187 | pt2b | 3 |
| 188 | pur-h | 3 |
| 189 | rasilez | 3 |
| 190 | rcof1 | 3 |
| 191 | re-excisions | 3 |
| 192 | rp-pp | 3 |
| 193 | slow-progressors | 3 |
| 194 | sr1664 | 3 |
| 195 | sylhetis | 3 |
| 196 | tgn1412 | 3 |
| 197 | untreated-animals | 3 |
| 198 | val30met | 3 |
| 199 | video-group | 3 |
| 200 | xyng1-1b43 | 3 |
| 201 | δco | 3 |
| 202 | 0.03s | 2 |
| 203 | 1000/microliters | 2 |
| 204 | 132° | 2 |
| 205 | 14-helix | 2 |
| 206 | 1:11 | 2 |
| 207 | 1fg | 2 |
| 208 | 24-month-olds | 2 |
| 209 | 25/56 | 2 |
| 210 | 26/104 | 2 |
| 211 | 2×-pedot-mg | 2 |
| 212 | 400ug/day | 2 |
| 213 | 500x10 | 2 |
| 214 | 5950 | 2 |
| 215 | 6.0×10 | 2 |
| 216 | 6.25x10 | 2 |
| 217 | 70rv86e50q | 2 |
| 218 | 75×10 | 2 |
| 219 | 80db | 2 |
| 220 | 880°c/min | 2 |
| 221 | 99/1 | 2 |
| 222 | adiponutrin | 2 |
| 223 | advance-2 | 2 |
| 224 | antiexposure | 2 |
| 225 | baal | 2 |
| 226 | borg-scale | 2 |
| 227 | butrans | 2 |
| 228 | case-managers | 2 |
| 229 | ceftazidime/linezolid | 2 |
| 230 | ceporin | 2 |
| 231 | chvmp | 2 |
| 232 | con-hl | 2 |
| 233 | con-patients | 2 |
| 234 | csl10 | 2 |
| 235 | darditillafelina | 2 |
| 236 | depsidones | 2 |
| 237 | dexamethasone-placebo | 2 |
| 238 | disease-free- | 2 |
| 239 | dishabituation | 2 |
| 240 | dmku-rp301 | 2 |
| 241 | egfr-epi | 2 |
| 242 | electricus | 2 |
| 243 | end-organs | 2 |
| 244 | ethyl-2- | 2 |
| 245 | fcεriα | 2 |
| 246 | fh01 | 2 |
| 247 | fullterms | 2 |
| 248 | ga-group | 2 |
| 249 | gonochorists | 2 |
| 250 | h/ha | 2 |
| 251 | hd-patients | 2 |
| 252 | hemicallotasis | 2 |
| 253 | hydroxuyrea | 2 |
| 254 | ileostomists | 2 |
| 255 | l/la | 2 |
| 256 | lgmd2e | 2 |
| 257 | ln-dp-xerogel | 2 |
| 258 | long-term-group | 2 |
| 259 | lovs | 2 |
| 260 | low-worriers | 2 |
| 261 | mdapga2 | 2 |
| 262 | metformin-placebo | 2 |
| 263 | methylphenidate-like | 2 |
| 264 | mp_dia | 2 |
| 265 | nalfon | 2 |
| 266 | non-anaemics | 2 |
| 267 | non-apneics | 2 |
| 268 | non-hibernators | 2 |
| 269 | non-massage | 2 |
| 270 | non-mtps | 2 |
| 271 | non-pharmacists | 2 |
| 272 | non-relapsers | 2 |
| 273 | non-rmf | 2 |
| 274 | non-vaccinees | 2 |
| 275 | nonachievers | 2 |
| 276 | nonbronchiolitics | 2 |
| 277 | noncyclers | 2 |
| 278 | nondouchers | 2 |
| 279 | nonmenthols | 2 |
| 280 | nonresponders/relapsers | 2 |
| 281 | npca | 2 |
| 282 | number-needed-to-treat/harm | 2 |
| 283 | numbers-needed-to-treat/harm | 2 |
| 284 | over-medication | 2 |
| 285 | penicillian | 2 |
| 286 | pept2*2/*2 | 2 |
| 287 | persantine | 2 |
| 288 | phenazone | 2 |
| 289 | pincers | 2 |
| 290 | placebo.2 | 2 |
| 291 | post-mbsr | 2 |
| 292 | ppd-rt23 | 2 |
| 293 | pr+nr | 2 |
| 294 | pre-pdt | 2 |
| 295 | preaching | 2 |
| 296 | qsb | 2 |
| 297 | r-peak | 2 |
| 298 | rtw-coordinator | 2 |
| 299 | short-carriers | 2 |
| 300 | shr-mt | 2 |
| 301 | sm22 | 2 |
| 302 | spot-morning | 2 |
| 303 | sra-hsp-17.2 | 2 |
| 304 | sub-epicardial | 2 |
| 305 | survival/recurrence | 2 |
| 306 | t-carriers | 2 |
| 307 | taido-funin | 2 |
| 308 | tastelessness | 2 |
| 309 | tcp-1 | 2 |
| 310 | tedral | 2 |
| 311 | tlv+furo | 2 |
| 312 | tm-3 | 2 |
| 313 | tprv1 | 2 |
| 314 | tr33t5 | 2 |
| 315 | unloaders | 2 |
| 316 | vincristine-adriamycin-dexamethasone | 2 |
| 317 | yp7 | 2 |
| 318 | £39,800/qaly | 2 |
| 319 | β-microseminoprotein | 2 |
| 320 | 1.35×10 | 1 |
| 321 | 1.8j/cm | 1 |
| 322 | 104,808 | 1 |
| 323 | 15s/min | 1 |
| 324 | 15tha | 1 |
| 325 | 17,265 | 1 |
| 326 | 2-phenylaminoadenosine | 1 |
| 327 | 2.0µgg | 1 |
| 328 | 245/753 | 1 |
| 329 | 28.1±19.1 | 1 |
| 330 | 38,253 | 1 |
| 331 | 3h/d | 1 |
| 332 | 4,5,6,7-tetrabromobenzotriazole | 1 |
| 333 | 4-meal-fed | 1 |
| 334 | 4000mg/kg | 1 |
| 335 | 5μsv/h | 1 |
| 336 | 6-mecaptopurine | 1 |
| 337 | 60ml/min/1,73m | 1 |
| 338 | 60w/m | 1 |
| 339 | 750×10 | 1 |
| 340 | 9-repeat-allele | 1 |
| 341 | african–american | 1 |
| 342 | age-gender-education | 1 |
| 343 | age/sex/bp | 1 |
| 344 | agriculturists | 1 |
| 345 | ar45 | 1 |
| 346 | artesunate-sulphadoxine-pyrimethamine | 1 |
| 347 | artiodactyl | 1 |
| 348 | behavious | 1 |
| 349 | bmcl-200908069-1 | 1 |
| 350 | body-masses | 1 |
| 351 | celebrity-judgments | 1 |
| 352 | control/case | 1 |
| 353 | d-aamphetamine | 1 |
| 354 | design/fitting | 1 |
| 355 | deteriorating- | 1 |
| 356 | doxycycline-rifampicin-aminoglycoside | 1 |
| 357 | episodic/recurrent | 1 |
| 358 | ex-io | 1 |
| 359 | forlrygbp | 1 |
| 360 | gbr-12909 | 1 |
| 361 | hieu | 1 |
| 362 | hmy2.cir | 1 |
| 363 | imdapril | 1 |
| 364 | individualsand | 1 |
| 365 | invitee | 1 |
| 366 | ivssg | 1 |
| 367 | ivus-mla | 1 |
| 368 | l861r/l861q | 1 |
| 369 | leg=44.3° | 1 |
| 370 | mass/year | 1 |
| 371 | mct-negative | 1 |
| 372 | methotrexat/5-fu | 1 |
| 373 | mifepristone/pg05 | 1 |
| 374 | mip-1405 | 1 |
| 375 | mri-selected | 1 |
| 376 | multipars | 1 |
| 377 | non-malay | 1 |
| 378 | non-molars | 1 |
| 379 | non-prostitutes | 1 |
| 380 | nondancer | 1 |
| 381 | nonminorities | 1 |
| 382 | nonwatchers | 1 |
| 383 | one-in-nine | 1 |
| 384 | openvbg-rygbp | 1 |
| 385 | p+ci | 1 |
| 386 | pallhypaesthesia | 1 |
| 387 | pastimes | 1 |
| 388 | pesons | 1 |
| 389 | pound1000 | 1 |
| 390 | pr180 | 1 |
| 391 | pre-wash | 1 |
| 392 | prpds | 1 |
| 393 | renters | 1 |
| 394 | sch58261 | 1 |
| 395 | seselin | 1 |
| 396 | sex-distribution | 1 |
| 397 | sylheti | 1 |
| 398 | time-controls | 1 |
| 399 | topics-ht | 1 |
| 400 | v-rg® | 1 |
| 401 | white-browed | 1 |
| 402 | xanthyletin | 1 |
| 403 | £1200 | 1 |
| 1 | 0.03s | 2 |
| 2 | 1,000/microl | 3 |
| 3 | 1,3-bisphosphoglycerate | 6 |
| 4 | 1-octadecene | 3 |
| 5 | 1.183 | 3 |
| 6 | 1.35×10 | 1 |
| 7 | 1.8j/cm | 1 |
| 8 | 10-year-olds | 14 |
| 9 | 1000/microliters | 2 |
| 10 | 1000g | 5 |
| 11 | 104,808 | 1 |
| 12 | 12/31/2011 | 3 |
| 13 | 12/37 | 3 |
| 14 | 132° | 2 |
| 15 | 14-helix | 2 |
| 16 | 14-year-olds | 8 |
| 17 | 15s/min | 1 |
| 18 | 15tha | 1 |
| 19 | 16/58 | 4 |
| 20 | 17,265 | 1 |
| 21 | 18-year-olds | 11 |
| 22 | 1:11 | 2 |
| 23 | 1fg | 2 |
| 24 | 2-phenylaminoadenosine | 1 |
| 25 | 2-year-olds | 15 |
| 26 | 2.0µgg | 1 |
| 27 | 24-month-olds | 2 |
| 28 | 245/753 | 1 |
| 29 | 25/56 | 2 |
| 30 | 26/104 | 2 |
| 31 | 28.1±19.1 | 1 |
| 32 | 2×-pedot-mg | 2 |
| 33 | 38,253 | 1 |
| 34 | 3h/d | 1 |
| 35 | 4,5,6,7-tetrabromobenzotriazole | 1 |
| 36 | 4-meal-fed | 1 |
| 37 | 4000mg/kg | 1 |
| 38 | 400ug/day | 2 |
| 39 | 45.2°c | 3 |
| 40 | 500x10 | 2 |
| 41 | 58/70 | 3 |
| 42 | 5950 | 2 |
| 43 | 5μsv/h | 1 |
| 44 | 6-mecaptopurine | 1 |
| 45 | 6.0×10 | 2 |
| 46 | 6.25x10 | 2 |
| 47 | 60ml/min/1,73m | 1 |
| 48 | 60w/m | 1 |
| 49 | 7-year-olds | 20 |
| 50 | 70rv86e50q | 2 |
| 51 | 750×10 | 1 |
| 52 | 75×10 | 2 |
| 53 | 80/81 | 3 |
| 54 | 80db | 2 |
| 55 | 880°c/min | 2 |
| 56 | 9-repeat-allele | 1 |
| 57 | 99/1 | 2 |
| 58 | abled-bodied | 3 |
| 59 | abt-200 | 4 |
| 60 | achdf | 5 |
| 61 | adiponutrin | 2 |
| 62 | adv1 | 3 |
| 63 | advance-2 | 2 |
| 64 | african–american | 1 |
| 65 | age-gender-education | 1 |
| 66 | age/sex/bp | 1 |
| 67 | agriculturists | 1 |
| 68 | aklavik | 4 |
| 69 | anapen | 14 |
| 70 | antiexposure | 2 |
| 71 | apneics | 3 |
| 72 | ar45 | 1 |
| 73 | arf-1 | 4 |
| 74 | artesunate-sulphadoxine-pyrimethamine | 1 |
| 75 | artiodactyl | 1 |
| 76 | arvms | 3 |
| 77 | as+mq | 7 |
| 78 | av2s3 | 7 |
| 79 | baal | 2 |
| 80 | babble | 8 |
| 81 | behavious | 1 |
| 82 | bmcl-200908069-1 | 1 |
| 83 | body-masses | 1 |
| 84 | borg-scale | 2 |
| 85 | bud200 | 3 |
| 86 | butrans | 2 |
| 87 | c-patients | 5 |
| 88 | case-managers | 2 |
| 89 | cbt+gn | 3 |
| 90 | cc5 | 3 |
| 91 | ccept | 6 |
| 92 | ceftazidime/linezolid | 2 |
| 93 | celebrity-judgments | 1 |
| 94 | ceporin | 2 |
| 95 | cervicograms | 4 |
| 96 | children/parents | 3 |
| 97 | chvmp | 2 |
| 98 | cntr | 4 |
| 99 | colostrum/milk | 7 |
| 100 | compocool-wb | 3 |
| 101 | con-hl | 2 |
| 102 | con-patients | 2 |
| 103 | control-infants | 5 |
| 104 | control/case | 1 |
| 105 | controls | 25,164 |
| 106 | cpb-cabg | 3 |
| 107 | cq+s+p | 3 |
| 108 | csl10 | 2 |
| 109 | ctbna | 8 |
| 110 | d-aamphetamine | 1 |
| 111 | dads | 27 |
| 112 | darditillafelina | 2 |
| 113 | dbercp | 9 |
| 114 | dbhc | 6 |
| 115 | dc3 | 4 |
| 116 | ddst-ii | 8 |
| 117 | defend-1 | 3 |
| 118 | depsidones | 2 |
| 119 | design/fitting | 1 |
| 120 | deteriorating- | 1 |
| 121 | dexamethasone-placebo | 2 |
| 122 | diastology | 4 |
| 123 | disease-free- | 2 |
| 124 | dishabituation | 2 |
| 125 | dmku-rp301 | 2 |
| 126 | dodecanol | 3 |
| 127 | doxycycline-rifampicin-aminoglycoside | 1 |
| 128 | dromedaries | 11 |
| 129 | e-pmma-b-pmps/sio2 | 3 |
| 130 | ec-dl | 6 |
| 131 | egfr-epi | 2 |
| 132 | elderlies | 7 |
| 133 | electricus | 2 |
| 134 | end-organs | 2 |
| 135 | epalrestat | 3 |
| 136 | epiderm | 3 |
| 137 | episodic/recurrent | 1 |
| 138 | escherichia/shigella | 3 |
| 139 | ethyl-2- | 2 |
| 140 | european-americans | 4 |
| 141 | evidence-based-medicine | 3 |
| 142 | ex-io | 1 |
| 143 | exercises/advice | 3 |
| 144 | f52 | 8 |
| 145 | fainters | 4 |
| 146 | fcεriα | 2 |
| 147 | fh01 | 2 |
| 148 | forlrygbp | 1 |
| 149 | formula-feeders | 6 |
| 150 | fullterms | 2 |
| 151 | g32 | 7 |
| 152 | ga-group | 2 |
| 153 | ga20 | 3 |
| 154 | gbr-12909 | 1 |
| 155 | gonochorists | 2 |
| 156 | group-bar | 3 |
| 157 | group-nc | 4 |
| 158 | h-br | 8 |
| 159 | h/ha | 2 |
| 160 | hca-apn | 9 |
| 161 | hcv-g1 | 6 |
| 162 | hd-patients | 2 |
| 163 | hemicallotasis | 2 |
| 164 | hieu | 1 |
| 165 | hispanic/latinos | 3 |
| 166 | hmy2.cir | 1 |
| 167 | htn-12wk | 5 |
| 168 | hydroxuyrea | 2 |
| 169 | hyperopes | 4 |
| 170 | hypochondroplasia | 3 |
| 171 | i.c.u | 12 |
| 172 | ileostomists | 2 |
| 173 | imdapril | 1 |
| 174 | imip/cs | 3 |
| 175 | individualsand | 1 |
| 176 | integuseal | 6 |
| 177 | invitee | 1 |
| 178 | iso+c | 4 |
| 179 | ivssg | 1 |
| 180 | ivus-mla | 1 |
| 181 | l-advp | 7 |
| 182 | l/la | 2 |
| 183 | l861r/l861q | 1 |
| 184 | ldl-cholesterolemia | 3 |
| 185 | le- | 5 |
| 186 | leg=44.3° | 1 |
| 187 | leutivit | 5 |
| 188 | lgmd2e | 2 |
| 189 | ln-dp-xerogel | 2 |
| 190 | logbooks | 17 |
| 191 | long-term-group | 2 |
| 192 | lovs | 2 |
| 193 | lovt | 5 |
| 194 | low-worriers | 2 |
| 195 | lowlanders | 24 |
| 196 | lps-dc | 4 |
| 197 | lr-ca | 8 |
| 198 | m-aci | 6 |
| 199 | ma- | 4 |
| 200 | mass/year | 1 |
| 201 | mct-negative | 1 |
| 202 | mdapga2 | 2 |
| 203 | mefloquine-artesunate | 10 |
| 204 | metformin-placebo | 2 |
| 205 | methotrexat/5-fu | 1 |
| 206 | methylphenidate-like | 2 |
| 207 | mets-pla | 3 |
| 208 | mifepristone/pg05 | 1 |
| 209 | mig-2 | 3 |
| 210 | mip-1405 | 1 |
| 211 | mncc-tt | 5 |
| 212 | monolinguals | 15 |
| 213 | moroccans | 4 |
| 214 | moxotó | 3 |
| 215 | mp_dia | 2 |
| 216 | mri-selected | 1 |
| 217 | multipars | 1 |
| 218 | nalfon | 2 |
| 219 | nct00038727 | 3 |
| 220 | never-douchers | 3 |
| 221 | non-/modest- | 4 |
| 222 | non-aas | 10 |
| 223 | non-alcoholics | 3 |
| 224 | non-anaemics | 2 |
| 225 | non-apneics | 2 |
| 226 | non-bathers | 7 |
| 227 | non-converters | 5 |
| 228 | non-diabetics | 138 |
| 229 | non-drinkers | 52 |
| 230 | non-ee-des | 3 |
| 231 | non-emp | 3 |
| 232 | non-firefighters | 8 |
| 233 | non-gymnasts | 3 |
| 234 | non-healers | 7 |
| 235 | non-hibernators | 2 |
| 236 | non-immigrants | 4 |
| 237 | non-injectors | 4 |
| 238 | non-malay | 1 |
| 239 | non-massage | 2 |
| 240 | non-molars | 1 |
| 241 | non-mtps | 2 |
| 242 | non-octogenarians | 4 |
| 243 | non-pharmacists | 2 |
| 244 | non-prostitutes | 1 |
| 245 | non-recruiters | 5 |
| 246 | non-relapsers | 2 |
| 247 | non-repeaters | 5 |
| 248 | non-rmf | 2 |
| 249 | non-sao-patients | 6 |
| 250 | non-smokers | 581 |
| 251 | non-switchers | 3 |
| 252 | non-tasters | 10 |
| 253 | non-tnbc | 8 |
| 254 | non-vaccinees | 2 |
| 255 | non-vegetarians | 22 |
| 256 | nonachievers | 2 |
| 257 | nonblacks | 21 |
| 258 | nonbronchiolitics | 2 |
| 259 | noncarriers | 132 |
| 260 | noncyclers | 2 |
| 261 | nondancer | 1 |
| 262 | nondancers | 5 |
| 263 | nondiabetics | 156 |
| 264 | nondouchers | 2 |
| 265 | nondrinkers | 38 |
| 266 | nonhypertensives | 4 |
| 267 | nonimprovers | 5 |
| 268 | noninitiators | 3 |
| 269 | noninsomniacs | 3 |
| 270 | nonjoggers | 4 |
| 271 | nonmenthols | 2 |
| 272 | nonminorities | 1 |
| 273 | nonmusicians | 13 |
| 274 | nonoctogenarians | 4 |
| 275 | nonresponders/relapsers | 2 |
| 276 | nonsmokers | 525 |
| 277 | nontriptans | 3 |
| 278 | nonwatchers | 1 |
| 279 | normals | 180 |
| 280 | normolipidemics | 7 |
| 281 | normotensives | 170 |
| 282 | npca | 2 |
| 283 | nrfhr | 4 |
| 284 | ntls | 6 |
| 285 | number-needed-to-treat/harm | 2 |
| 286 | numbers-needed-to-treat/harm | 2 |
| 287 | obeses | 4 |
| 288 | oihr | 20 |
| 289 | olysetnet | 3 |
| 290 | om-only | 4 |
| 291 | omnivores | 58 |
| 292 | one-in-nine | 1 |
| 293 | openvbg-rygbp | 1 |
| 294 | over-medication | 2 |
| 295 | p+ci | 1 |
| 296 | p.r | 6 |
| 297 | p48 | 4 |
| 298 | p56 | 3 |
| 299 | pallhypaesthesia | 1 |
| 300 | papls | 6 |
| 301 | parents/patients | 3 |
| 302 | pastimes | 1 |
| 303 | pbcs | 11 |
| 304 | pd51 | 3 |
| 305 | penicillian | 2 |
| 306 | pept2*2/*2 | 2 |
| 307 | persantine | 2 |
| 308 | pesons | 1 |
| 309 | phenazone | 2 |
| 310 | phononics | 3 |
| 311 | phq-deniers | 5 |
| 312 | pincers | 2 |
| 313 | placebo.2 | 2 |
| 314 | pneumonia-pp | 4 |
| 315 | post-mbsr | 2 |
| 316 | postneonates | 4 |
| 317 | poultices | 3 |
| 318 | pound1000 | 1 |
| 319 | ppd-rt23 | 2 |
| 320 | pr+nr | 2 |
| 321 | pr180 | 1 |
| 322 | pre-emergence | 3 |
| 323 | pre-pdt | 2 |
| 324 | pre-wash | 1 |
| 325 | preaching | 2 |
| 326 | prednisolone- | 4 |
| 327 | propranolol+hfa-bdp100 | 3 |
| 328 | prpds | 1 |
| 329 | pt2b | 3 |
| 330 | pur-h | 3 |
| 331 | pwh-o | 5 |
| 332 | qsb | 2 |
| 333 | r-peak | 2 |
| 334 | r16 | 9 |
| 335 | rasilez | 3 |
| 336 | rcof1 | 3 |
| 337 | re-excisions | 3 |
| 338 | renters | 1 |
| 339 | rp-pp | 3 |
| 340 | rtw-coordinator | 2 |
| 341 | s-tha | 5 |
| 342 | sch58261 | 1 |
| 343 | sdct | 12 |
| 344 | seadiet | 6 |
| 345 | second-borns | 4 |
| 346 | seselin | 1 |
| 347 | sex-distribution | 1 |
| 348 | shoola | 10 |
| 349 | short-carriers | 2 |
| 350 | shr-mt | 2 |
| 351 | slow-progressors | 3 |
| 352 | sm22 | 2 |
| 353 | smex | 13 |
| 354 | sow10 | 4 |
| 355 | spot-morning | 2 |
| 356 | sr1664 | 3 |
| 357 | sra-hsp-17.2 | 2 |
| 358 | srp+placebo | 8 |
| 359 | sub-epicardial | 2 |
| 360 | suhr | 7 |
| 361 | survival/recurrence | 2 |
| 362 | sylheti | 1 |
| 363 | sylhetis | 3 |
| 364 | t-carriers | 2 |
| 365 | tacrolimus/mmf/steroids | 4 |
| 366 | taido-funin | 2 |
| 367 | tastelessness | 2 |
| 368 | tcp-1 | 2 |
| 369 | tedral | 2 |
| 370 | teedlw | 4 |
| 371 | teetotalers | 7 |
| 372 | tetraploids | 4 |
| 373 | tgn1412 | 3 |
| 374 | time-controls | 1 |
| 375 | tlv+furo | 2 |
| 376 | tm-3 | 2 |
| 377 | topics-ht | 1 |
| 378 | tprv1 | 2 |
| 379 | tr33t5 | 2 |
| 380 | unloaders | 2 |
| 381 | untreated-animals | 3 |
| 382 | urixin | 5 |
| 383 | v-rg | 9 |
| 384 | v-rg® | 1 |
| 385 | val30met | 3 |
| 386 | video-group | 3 |
| 387 | vincristine-adriamycin-dexamethasone | 2 |
| 388 | vit2 | 4 |
| 389 | voh | 8 |
| 390 | white-browed | 1 |
| 391 | wild-types | 10 |
| 392 | wing-a | 4 |
| 393 | wky-sed | 5 |
| 394 | woreda | 4 |
| 395 | xanthyletin | 1 |
| 396 | xyng1-1b43 | 3 |
| 397 | yp7 | 2 |
| 398 | zes-fr | 6 |
| 399 | £1200 | 1 |
| 400 | £39,800/qaly | 2 |
| 401 | α-synucleinopathies | 6 |
| 402 | β-microseminoprotein | 2 |
| 403 | δco | 3 |
| 1 | ethyl-2- | 2 |
| 2 | ma- | 4 |
| 3 | disease-free- | 2 |
| 4 | le- | 5 |
| 5 | prednisolone- | 4 |
| 6 | deteriorating- | 1 |
| 7 | non-/modest- | 4 |
| 8 | pound1000 | 1 |
| 9 | propranolol+hfa-bdp100 | 3 |
| 10 | abt-200 | 4 |
| 11 | £1200 | 1 |
| 12 | bud200 | 3 |
| 13 | csl10 | 2 |
| 14 | sow10 | 4 |
| 15 | 500x10 | 2 |
| 16 | 6.25x10 | 2 |
| 17 | 6.0×10 | 2 |
| 18 | 750×10 | 1 |
| 19 | 1.35×10 | 1 |
| 20 | 75×10 | 2 |
| 21 | ga20 | 3 |
| 22 | 5950 | 2 |
| 23 | 58/70 | 3 |
| 24 | pr180 | 1 |
| 25 | bmcl-200908069-1 | 1 |
| 26 | defend-1 | 3 |
| 27 | arf-1 | 4 |
| 28 | tcp-1 | 2 |
| 29 | 28.1±19.1 | 1 |
| 30 | 99/1 | 2 |
| 31 | dmku-rp301 | 2 |
| 32 | fh01 | 2 |
| 33 | 12/31/2011 | 3 |
| 34 | 1:11 | 2 |
| 35 | pd51 | 3 |
| 36 | sch58261 | 1 |
| 37 | 80/81 | 3 |
| 38 | rcof1 | 3 |
| 39 | hcv-g1 | 6 |
| 40 | adv1 | 3 |
| 41 | tprv1 | 2 |
| 42 | pept2*2/*2 | 2 |
| 43 | advance-2 | 2 |
| 44 | mig-2 | 3 |
| 45 | sra-hsp-17.2 | 2 |
| 46 | placebo.2 | 2 |
| 47 | tgn1412 | 3 |
| 48 | sm22 | 2 |
| 49 | g32 | 7 |
| 50 | f52 | 8 |
| 51 | mdapga2 | 2 |
| 52 | e-pmma-b-pmps/sio2 | 3 |
| 53 | vit2 | 4 |
| 54 | tm-3 | 2 |
| 55 | ppd-rt23 | 2 |
| 56 | xyng1-1b43 | 3 |
| 57 | 38,253 | 1 |
| 58 | 245/753 | 1 |
| 59 | 1.183 | 3 |
| 60 | dc3 | 4 |
| 61 | av2s3 | 7 |
| 62 | 26/104 | 2 |
| 63 | sr1664 | 3 |
| 64 | mip-1405 | 1 |
| 65 | mifepristone/pg05 | 1 |
| 66 | ar45 | 1 |
| 67 | 17,265 | 1 |
| 68 | cc5 | 3 |
| 69 | tr33t5 | 2 |
| 70 | r16 | 9 |
| 71 | 25/56 | 2 |
| 72 | p56 | 3 |
| 73 | nct00038727 | 3 |
| 74 | 12/37 | 3 |
| 75 | yp7 | 2 |
| 76 | 104,808 | 1 |
| 77 | p48 | 4 |
| 78 | 16/58 | 4 |
| 79 | gbr-12909 | 1 |
| 80 | wing-a | 4 |
| 81 | lr-ca | 8 |
| 82 | npca | 2 |
| 83 | woreda | 4 |
| 84 | hydroxuyrea | 2 |
| 85 | h/ha | 2 |
| 86 | s-tha | 5 |
| 87 | 15tha | 1 |
| 88 | mp_dia | 2 |
| 89 | ldl-cholesterolemia | 3 |
| 90 | hypochondroplasia | 3 |
| 91 | pallhypaesthesia | 1 |
| 92 | l/la | 2 |
| 93 | escherichia/shigella | 3 |
| 94 | ivus-mla | 1 |
| 95 | shoola | 10 |
| 96 | mets-pla | 3 |
| 97 | ctbna | 8 |
| 98 | darditillafelina | 2 |
| 99 | pt2b | 3 |
| 100 | 80db | 2 |
| 101 | qsb | 2 |
| 102 | compocool-wb | 3 |
| 103 | iso+c | 4 |
| 104 | non-tnbc | 8 |
| 105 | lps-dc | 4 |
| 106 | dbhc | 6 |
| 107 | group-nc | 4 |
| 108 | 45.2°c | 3 |
| 109 | 3h/d | 1 |
| 110 | 4-meal-fed | 1 |
| 111 | abled-bodied | 3 |
| 112 | wky-sed | 5 |
| 113 | mri-selected | 1 |
| 114 | white-browed | 1 |
| 115 | ceftazidime/linezolid | 2 |
| 116 | individualsand | 1 |
| 117 | lgmd2e | 2 |
| 118 | exercises/advice | 3 |
| 119 | pre-emergence | 3 |
| 120 | survival/recurrence | 2 |
| 121 | doxycycline-rifampicin-aminoglycoside | 1 |
| 122 | invitee | 1 |
| 123 | non-massage | 2 |
| 124 | methylphenidate-like | 2 |
| 125 | borg-scale | 2 |
| 126 | babble | 8 |
| 127 | 9-repeat-allele | 1 |
| 128 | 4,5,6,7-tetrabromobenzotriazole | 1 |
| 129 | 1-octadecene | 3 |
| 130 | evidence-based-medicine | 3 |
| 131 | artesunate-sulphadoxine-pyrimethamine | 1 |
| 132 | d-aamphetamine | 1 |
| 133 | one-in-nine | 1 |
| 134 | 6-mecaptopurine | 1 |
| 135 | 2-phenylaminoadenosine | 1 |
| 136 | persantine | 2 |
| 137 | vincristine-adriamycin-dexamethasone | 2 |
| 138 | phenazone | 2 |
| 139 | antiexposure | 2 |
| 140 | control/case | 1 |
| 141 | mefloquine-artesunate | 10 |
| 142 | 1,3-bisphosphoglycerate | 6 |
| 143 | mct-negative | 1 |
| 144 | achdf | 5 |
| 145 | non-rmf | 2 |
| 146 | 1000g | 5 |
| 147 | cpb-cabg | 3 |
| 148 | 1fg | 2 |
| 149 | 2.0µgg | 1 |
| 150 | 4000mg/kg | 1 |
| 151 | 2×-pedot-mg | 2 |
| 152 | preaching | 2 |
| 153 | spot-morning | 2 |
| 154 | design/fitting | 1 |
| 155 | v-rg | 9 |
| 156 | ivssg | 1 |
| 157 | pur-h | 3 |
| 158 | 5μsv/h | 1 |
| 159 | voh | 8 |
| 160 | pre-wash | 1 |
| 161 | p+ci | 1 |
| 162 | m-aci | 6 |
| 163 | ddst-ii | 8 |
| 164 | egfr-epi | 2 |
| 165 | sylheti | 1 |
| 166 | r-peak | 2 |
| 167 | aklavik | 4 |
| 168 | colostrum/milk | 7 |
| 169 | htn-12wk | 5 |
| 170 | baal | 2 |
| 171 | integuseal | 6 |
| 172 | sub-epicardial | 2 |
| 173 | tedral | 2 |
| 174 | ec-dl | 6 |
| 175 | ln-dp-xerogel | 2 |
| 176 | con-hl | 2 |
| 177 | imdapril | 1 |
| 178 | dodecanol | 3 |
| 179 | 1,000/microl | 3 |
| 180 | artiodactyl | 1 |
| 181 | 60w/m | 1 |
| 182 | 60ml/min/1,73m | 1 |
| 183 | 1.8j/cm | 1 |
| 184 | number-needed-to-treat/harm | 2 |
| 185 | numbers-needed-to-treat/harm | 2 |
| 186 | epiderm | 3 |
| 187 | african–american | 1 |
| 188 | penicillian | 2 |
| 189 | anapen | 14 |
| 190 | cbt+gn | 3 |
| 191 | β-microseminoprotein | 2 |
| 192 | seselin | 1 |
| 193 | 880°c/min | 2 |
| 194 | 15s/min | 1 |
| 195 | taido-funin | 2 |
| 196 | ceporin | 2 |
| 197 | adiponutrin | 2 |
| 198 | xanthyletin | 1 |
| 199 | urixin | 5 |
| 200 | nalfon | 2 |
| 201 | over-medication | 2 |
| 202 | age-gender-education | 1 |
| 203 | dishabituation | 2 |
| 204 | sex-distribution | 1 |
| 205 | hca-apn | 9 |
| 206 | pwh-o | 5 |
| 207 | srp+placebo | 8 |
| 208 | dexamethasone-placebo | 2 |
| 209 | metformin-placebo | 2 |
| 210 | δco | 3 |
| 211 | ex-io | 1 |
| 212 | tlv+furo | 2 |
| 213 | cq+s+p | 3 |
| 214 | age/sex/bp | 1 |
| 215 | openvbg-rygbp | 1 |
| 216 | forlrygbp | 1 |
| 217 | dbercp | 9 |
| 218 | non-emp | 3 |
| 219 | chvmp | 2 |
| 220 | pneumonia-pp | 4 |
| 221 | rp-pp | 3 |
| 222 | ga-group | 2 |
| 223 | long-term-group | 2 |
| 224 | video-group | 3 |
| 225 | l-advp | 7 |
| 226 | 70rv86e50q | 2 |
| 227 | l861r/l861q | 1 |
| 228 | as+mq | 7 |
| 229 | p.r | 6 |
| 230 | group-bar | 3 |
| 231 | mass/year | 1 |
| 232 | h-br | 8 |
| 233 | nondancer | 1 |
| 234 | zes-fr | 6 |
| 235 | nrfhr | 4 |
| 236 | oihr | 20 |
| 237 | suhr | 7 |
| 238 | hmy2.cir | 1 |
| 239 | pr+nr | 2 |
| 240 | rtw-coordinator | 2 |
| 241 | post-mbsr | 2 |
| 242 | cntr | 4 |
| 243 | 0.03s | 2 |
| 244 | non-aas | 10 |
| 245 | imip/cs | 3 |
| 246 | noninsomniacs | 3 |
| 247 | pbcs | 11 |
| 248 | apneics | 3 |
| 249 | non-apneics | 2 |
| 250 | non-alcoholics | 3 |
| 251 | non-anaemics | 2 |
| 252 | normolipidemics | 7 |
| 253 | phononics | 3 |
| 254 | non-diabetics | 138 |
| 255 | nondiabetics | 156 |
| 256 | nonbronchiolitics | 2 |
| 257 | dads | 27 |
| 258 | tetraploids | 4 |
| 259 | tacrolimus/mmf/steroids | 4 |
| 260 | 24-month-olds | 2 |
| 261 | 10-year-olds | 14 |
| 262 | 2-year-olds | 15 |
| 263 | 14-year-olds | 8 |
| 264 | 7-year-olds | 20 |
| 265 | 18-year-olds | 11 |
| 266 | prpds | 1 |
| 267 | poultices | 3 |
| 268 | non-ee-des | 3 |
| 269 | non-vaccinees | 2 |
| 270 | α-synucleinopathies | 6 |
| 271 | elderlies | 7 |
| 272 | dromedaries | 11 |
| 273 | nonminorities | 1 |
| 274 | pastimes | 1 |
| 275 | depsidones | 2 |
| 276 | hyperopes | 4 |
| 277 | wild-types | 10 |
| 278 | omnivores | 58 |
| 279 | obeses | 4 |
| 280 | body-masses | 1 |
| 281 | postneonates | 4 |
| 282 | non-prostitutes | 1 |
| 283 | normotensives | 170 |
| 284 | nonhypertensives | 4 |
| 285 | hemicallotasis | 2 |
| 286 | sylhetis | 3 |
| 287 | nonblacks | 21 |
| 288 | logbooks | 17 |
| 289 | untreated-animals | 3 |
| 290 | normals | 180 |
| 291 | monolinguals | 15 |
| 292 | nonmenthols | 2 |
| 293 | controls | 25,164 |
| 294 | time-controls | 1 |
| 295 | papls | 6 |
| 296 | ntls | 6 |
| 297 | cervicograms | 4 |
| 298 | fullterms | 2 |
| 299 | arvms | 3 |
| 300 | moroccans | 4 |
| 301 | european-americans | 4 |
| 302 | end-organs | 2 |
| 303 | nonmusicians | 13 |
| 304 | non-octogenarians | 4 |
| 305 | nonoctogenarians | 4 |
| 306 | non-vegetarians | 22 |
| 307 | butrans | 2 |
| 308 | nontriptans | 3 |
| 309 | re-excisions | 3 |
| 310 | pesons | 1 |
| 311 | second-borns | 4 |
| 312 | hispanic/latinos | 3 |
| 313 | non-mtps | 2 |
| 314 | non-molars | 1 |
| 315 | multipars | 1 |
| 316 | nondancers | 5 |
| 317 | pincers | 2 |
| 318 | unloaders | 2 |
| 319 | formula-feeders | 6 |
| 320 | lowlanders | 24 |
| 321 | case-managers | 2 |
| 322 | nonjoggers | 4 |
| 323 | nonwatchers | 1 |
| 324 | non-switchers | 3 |
| 325 | never-douchers | 3 |
| 326 | nondouchers | 2 |
| 327 | non-bathers | 7 |
| 328 | phq-deniers | 5 |
| 329 | t-carriers | 2 |
| 330 | short-carriers | 2 |
| 331 | noncarriers | 132 |
| 332 | low-worriers | 2 |
| 333 | non-drinkers | 52 |
| 334 | nondrinkers | 38 |
| 335 | non-smokers | 581 |
| 336 | nonsmokers | 525 |
| 337 | non-healers | 7 |
| 338 | teetotalers | 7 |
| 339 | noncyclers | 2 |
| 340 | non-relapsers | 2 |
| 341 | nonresponders/relapsers | 2 |
| 342 | non-repeaters | 5 |
| 343 | non-firefighters | 8 |
| 344 | 1000/microliters | 2 |
| 345 | non-recruiters | 5 |
| 346 | renters | 1 |
| 347 | fainters | 4 |
| 348 | non-converters | 5 |
| 349 | non-tasters | 10 |
| 350 | nonachievers | 2 |
| 351 | nonimprovers | 5 |
| 352 | slow-progressors | 3 |
| 353 | noninitiators | 3 |
| 354 | non-hibernators | 2 |
| 355 | non-injectors | 4 |
| 356 | tastelessness | 2 |
| 357 | control-infants | 5 |
| 358 | non-immigrants | 4 |
| 359 | c-patients | 5 |
| 360 | hd-patients | 2 |
| 361 | con-patients | 2 |
| 362 | non-sao-patients | 6 |
| 363 | parents/patients | 3 |
| 364 | celebrity-judgments | 1 |
| 365 | children/parents | 3 |
| 366 | non-gymnasts | 3 |
| 367 | non-pharmacists | 2 |
| 368 | ileostomists | 2 |
| 369 | gonochorists | 2 |
| 370 | agriculturists | 1 |
| 371 | electricus | 2 |
| 372 | behavious | 1 |
| 373 | lovs | 2 |
| 374 | epalrestat | 3 |
| 375 | sdct | 12 |
| 376 | pre-pdt | 2 |
| 377 | seadiet | 6 |
| 378 | val30met | 3 |
| 379 | olysetnet | 3 |
| 380 | topics-ht | 1 |
| 381 | leutivit | 5 |
| 382 | shr-mt | 2 |
| 383 | episodic/recurrent | 1 |
| 384 | ccept | 6 |
| 385 | mncc-tt | 5 |
| 386 | lovt | 5 |
| 387 | i.c.u | 12 |
| 388 | hieu | 1 |
| 389 | methotrexat/5-fu | 1 |
| 390 | teedlw | 4 |
| 391 | smex | 13 |
| 392 | 14-helix | 2 |
| 393 | 400ug/day | 2 |
| 394 | non-malay | 1 |
| 395 | diastology | 4 |
| 396 | £39,800/qaly | 2 |
| 397 | om-only | 4 |
| 398 | rasilez | 3 |
| 399 | v-rg® | 1 |
| 400 | 132° | 2 |
| 401 | leg=44.3° | 1 |
| 402 | fcεriα | 2 |
| 403 | moxotó | 3 |